Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Menopause in adult women with human papillomavirus: health-related quality of life and determinants.
Calvo-Torres J, Rejas J, Ramírez-Mena M, González-Granados C, Bradbury M, Del Pino M, Procas B, Rubio-Arroyo M, Presa-Lorite J, Gippini I, Fasero M, Fiol G, Romero P, Cohen A, Coronado PJ; HPV-QoL Study group. Calvo-Torres J, et al. Among authors: fasero m. Menopause. 2024 Sep 1;31(9):809-817. doi: 10.1097/GME.0000000000002395. Epub 2024 Aug 5. Menopause. 2024. PMID: 39186453
In reply.
Coronado PJ, Mendoza N, Fasero M. Coronado PJ, et al. Among authors: fasero m. Menopause. 2024 Nov 1;31(11):1028-1029. doi: 10.1097/GME.0000000000002430. Epub 2024 Aug 21. Menopause. 2024. PMID: 39162565 No abstract available.
POESIT recommendations on management of body-identical hormones in menopausal symptoms.
Palacios S, Rebelo C, Casquilho A, Costa AR, Cagnacci A, Cano A, Castelo-Branco C, Di Carlo C, Romão F, Geraldes F, Gambacciani M, Fasero M, Coronado P, Carvalho MJ, Nappi RE. Palacios S, et al. Among authors: fasero m. Climacteric. 2024 Aug;27(4):340-350. doi: 10.1080/13697137.2024.2368486. Epub 2024 Jul 8. Climacteric. 2024. PMID: 38978340 Review.
Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.
Coronado PJ, Gómez A, Iglesias E, Fasero M, Baquedano L, Sánchez S, Ramírez-Polo I, de la Viuda E, Otero B, Llaneza P, Mendoza N, Lubián DM; HMT Eligibility Criteria Group. Coronado PJ, et al. Among authors: fasero m. Menopause. 2024 Mar 1;31(3):234-242. doi: 10.1097/GME.0000000000002317. Menopause. 2024. PMID: 38385734
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
Mendoza N, Ramírez I, de la Viuda E, Coronado P, Baquedano L, Llaneza P, Nieto V, Otero B, Sánchez-Méndez S, de Frutos VÁ, Andraca L, Barriga P, Benítez Z, Bombas T, Cancelo MJ, Cano A, Branco CC, Correa M, Doval JL, Fasero M, Fiol G, Garello NC, Genazzani AR, Gómez AI, Gómez MÁ, González S, Goulis DG, Guinot M, Hernández LR, Herrero S, Iglesias E, Jurado AR, Lete I, Lubián D, Martínez M, Nieto A, Nieto L, Palacios S, Pedreira M, Pérez-Campos E, Plá MJ, Presa J, Quereda F, Ribes M, Romero P, Roca B, Sánchez-Capilla A, Sánchez-Borrego R, Santaballa A, Santamaría A, Simoncini T, Tinahones F, Calaf J. Mendoza N, et al. Among authors: fasero m. Maturitas. 2022 Dec;166:65-85. doi: 10.1016/j.maturitas.2022.08.008. Epub 2022 Aug 30. Maturitas. 2022. PMID: 36081216
31 results